These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 32532842)
1. Efficacy of medium chain triglyceride oil dietary supplementation in reducing seizure frequency in dogs with idiopathic epilepsy without cluster seizures: a non-blinded, prospective clinical trial. Molina J; Jean-Philippe C; Conboy L; Añor S; de la Fuente C; Wrzosek MA; Spycher A; Luchsinger E; Wenger-Riggenbach B; Montoliu P; Gandini G; Menchetti M; Ribeiro JC; Varejão A; Ferreira A; Zanghi B; Volk HA Vet Rec; 2020 Oct; 187(9):356. PubMed ID: 32532842 [TBL] [Abstract][Full Text] [Related]
2. A multicenter randomized controlled trial of medium-chain triglyceride dietary supplementation on epilepsy in dogs. Berk BA; Law TH; Packer RMA; Wessmann A; Bathen-Nöthen A; Jokinen TS; Knebel A; Tipold A; Pelligand L; Meads Z; Volk HA J Vet Intern Med; 2020 May; 34(3):1248-1259. PubMed ID: 32293065 [TBL] [Abstract][Full Text] [Related]
3. A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol. Berk BA; Packer RMA; Law TH; Wessmann A; Bathen-Nöthen A; Jokinen TS; Knebel A; Tipold A; Pelligand L; Volk HA BMC Vet Res; 2019 May; 15(1):181. PubMed ID: 31146740 [TBL] [Abstract][Full Text] [Related]
4. A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy. Law TH; Davies ES; Pan Y; Zanghi B; Want E; Volk HA Br J Nutr; 2015 Nov; 114(9):1438-47. PubMed ID: 26337751 [TBL] [Abstract][Full Text] [Related]
5. A six-month prospective, randomised, double-blinded, placebo-controlled, crossover, dietary trial design to investigate the potential of psychobiotics on seizure semiology and comorbidities in canine epilepsy: study protocol. Schmidt T; Meller S; Meyerhoff N; Twele F; Zanghi B; Volk HA BMC Vet Res; 2023 Mar; 19(1):57. PubMed ID: 36864510 [TBL] [Abstract][Full Text] [Related]
6. Investigating owner use of dietary supplements in dogs with idiopathic epilepsy. Berk BA; Packer RMA; Law TH; Volk HA Res Vet Sci; 2018 Aug; 119():276-284. PubMed ID: 30064067 [TBL] [Abstract][Full Text] [Related]
7. Effects of a ketogenic diet on ADHD-like behavior in dogs with idiopathic epilepsy. Packer RM; Law TH; Davies E; Zanghi B; Pan Y; Volk HA Epilepsy Behav; 2016 Feb; 55():62-8. PubMed ID: 26773515 [TBL] [Abstract][Full Text] [Related]
9. Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and/or potassium bromide. Chang Y; Mellor DJ; Anderson TJ J Small Anim Pract; 2006 Oct; 47(10):574-81. PubMed ID: 17004949 [TBL] [Abstract][Full Text] [Related]
10. Investigating the potential for seizure prediction in dogs with idiopathic epilepsy: owner-reported prodromal changes and seizure triggers. Finnegan SL; Volk HA; Asher L; Daley M; Packer RMA Vet Rec; 2020 Aug; 187(4):152. PubMed ID: 32444506 [TBL] [Abstract][Full Text] [Related]
11. Quality-of-life aspects in idiopathic epilepsy in dogs. Wessmann A; Volk HA; Packer RM; Ortega M; Anderson TJ Vet Rec; 2016 Sep; 179(9):229. PubMed ID: 27329504 [TBL] [Abstract][Full Text] [Related]
12. A prospective observational longitudinal study of new-onset seizures and newly diagnosed epilepsy in dogs. Fredsø N; Toft N; Sabers A; Berendt M BMC Vet Res; 2017 Feb; 13(1):54. PubMed ID: 28209153 [TBL] [Abstract][Full Text] [Related]
13. Metabolic fingerprinting of dogs with idiopathic epilepsy receiving a ketogenic medium-chain triglyceride (MCT) oil. Berk BA; Ottka C; Hong Law T; Packer RMA; Wessmann A; Bathen-Nöthen A; Jokinen TS; Knebel A; Tipold A; Lohi H; Volk HA Front Vet Sci; 2022; 9():935430. PubMed ID: 36277072 [TBL] [Abstract][Full Text] [Related]
14. Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency. Stee K; Martlé V; Broeckx BJG; Royaux E; Van Ham L; Bhatti SFM Vet J; 2017 Dec; 230():1-5. PubMed ID: 29208209 [TBL] [Abstract][Full Text] [Related]
15. Assessment into the usage of levetiracetam in a canine epilepsy clinic. Packer RM; Nye G; Porter SE; Volk HA BMC Vet Res; 2015 Feb; 11():25. PubMed ID: 25889090 [TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of imepitoin in the treatment of naive dogs affected by idiopathic epilepsy. Gallucci A; Gagliardo T; Menchetti M; Bianchi E; Bucci D; Gandini G Vet Rec; 2017 Aug; 181(6):144. PubMed ID: 28600446 [TBL] [Abstract][Full Text] [Related]
17. Th17 cell-mediated immune response in a subpopulation of dogs with idiopathic epilepsy. Knebel A; Kämpe A; Carlson R; Rohn K; Tipold A PLoS One; 2022; 17(1):e0262285. PubMed ID: 35025939 [TBL] [Abstract][Full Text] [Related]
18. Phenobarbital administration every eight hours: improvement of seizure management in idiopathic epileptic dogs with decreased phenobarbital elimination half-life. Stabile F; Barnett CR; De Risio L Vet Rec; 2017 Feb; 180(7):178. PubMed ID: 28062844 [TBL] [Abstract][Full Text] [Related]
19. Epilepsy beyond seizures: a review of the impact of epilepsy and its comorbidities on health-related quality of life in dogs. Packer RM; Volk HA Vet Rec; 2015 Sep; 177(12):306-15. PubMed ID: 26405128 [TBL] [Abstract][Full Text] [Related]
20. Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin. Royaux E; Van Ham L; Broeckx BJ; Van Soens I; Gielen I; Deforce D; Bhatti SF Vet J; 2017 Feb; 220():51-54. PubMed ID: 28190495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]